Global Intravitreal Injectable Supply, Demand and Key Producers, 2024-2030
Page: 100
Published Date: 27 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Intravitreal Injectable market size is expected to reach $ 23690 million by 2030, rising at a market growth of 6.8% CAGR during the forecast period (2024-2030).
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
This report studies the global Intravitreal Injectable production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravitreal Injectable, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravitreal Injectable that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravitreal Injectable total production and demand, 2019-2030, (K Units)
Global Intravitreal Injectable total production value, 2019-2030, (USD Million)
Global Intravitreal Injectable production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intravitreal Injectable consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Intravitreal Injectable domestic production, consumption, key domestic manufacturers and share
Global Intravitreal Injectable production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Intravitreal Injectable production by Drug, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intravitreal Injectable production by Disease production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Intravitreal Injectable market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravitreal Injectable market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Drug, and by Disease. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Intravitreal Injectable Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Intravitreal Injectable Market, Segmentation by Drug
Anti-VEGF
Steroids
Others
Global Intravitreal Injectable Market, Segmentation by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Companies Profiled:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Key Questions Answered
1. How big is the global Intravitreal Injectable market?
2. What is the demand of the global Intravitreal Injectable market?
3. What is the year over year growth of the global Intravitreal Injectable market?
4. What is the production and production value of the global Intravitreal Injectable market?
5. Who are the key producers in the global Intravitreal Injectable market?
Table of Contents
1 Supply Summary
1.1 Intravitreal Injectable Introduction
1.2 World Intravitreal Injectable Supply & Forecast
1.2.1 World Intravitreal Injectable Production Value (2019 & 2023 & 2030)
1.2.2 World Intravitreal Injectable Production (2019-2030)
1.2.3 World Intravitreal Injectable Pricing Trends (2019-2030)
1.3 World Intravitreal Injectable Production by Region (Based on Production Site)
1.3.1 World Intravitreal Injectable Production Value by Region (2019-2030)
1.3.2 World Intravitreal Injectable Production by Region (2019-2030)
1.3.3 World Intravitreal Injectable Average Price by Region (2019-2030)
1.3.4 North America Intravitreal Injectable Production (2019-2030)
1.3.5 Europe Intravitreal Injectable Production (2019-2030)
1.3.6 China Intravitreal Injectable Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravitreal Injectable Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravitreal Injectable Major Market Trends
2.1 World Intravitreal Injectable Demand (2019-2030)
2.2 World Intravitreal Injectable Consumption by Region
2.2.1 World Intravitreal Injectable Consumption by Region (2019-2024)
2.2.2 World Intravitreal Injectable Consumption Forecast by Region (2025-2030)
2.3 United States Intravitreal Injectable Consumption (2019-2030)
2.4 China Intravitreal Injectable Consumption (2019-2030)
2.5 Europe Intravitreal Injectable Consumption (2019-2030)
2.6 Japan Intravitreal Injectable Consumption (2019-2030)
2.7 South Korea Intravitreal Injectable Consumption (2019-2030)
2.8 ASEAN Intravitreal Injectable Consumption (2019-2030)
2.9 India Intravitreal Injectable Consumption (2019-2030)
3.1 World Intravitreal Injectable Production Value by Manufacturer (2019-2024)
3.2 World Intravitreal Injectable Production by Manufacturer (2019-2024)
3.3 World Intravitreal Injectable Average Price by Manufacturer (2019-2024)
3.4 Intravitreal Injectable Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravitreal Injectable Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravitreal Injectable in 2023
3.5.3 Global Concentration Ratios (CR8) for Intravitreal Injectable in 2023
3.6 Intravitreal Injectable Market: Overall Company Footprint Analysis
3.6.1 Intravitreal Injectable Market: Region Footprint
3.6.2 Intravitreal Injectable Market: Company Product Type Footprint
3.6.3 Intravitreal Injectable Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Intravitreal Injectable Production Value Comparison
4.1.1 United States VS China: Intravitreal Injectable Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Intravitreal Injectable Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Intravitreal Injectable Production Comparison
4.2.1 United States VS China: Intravitreal Injectable Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Intravitreal Injectable Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Intravitreal Injectable Consumption Comparison
4.3.1 United States VS China: Intravitreal Injectable Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Intravitreal Injectable Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Intravitreal Injectable Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravitreal Injectable Production Value (2019-2024)
4.4.3 United States Based Manufacturers Intravitreal Injectable Production (2019-2024)
4.5 China Based Intravitreal Injectable Manufacturers and Market Share
4.5.1 China Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravitreal Injectable Production Value (2019-2024)
4.5.3 China Based Manufacturers Intravitreal Injectable Production (2019-2024)
4.6 Rest of World Based Intravitreal Injectable Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravitreal Injectable Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Intravitreal Injectable Production (2019-2024)
5.1 World Intravitreal Injectable Market Size Overview by Drug: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Drug
5.2.1 Anti-VEGF
5.2.2 Steroids
5.2.3 Others
5.3 Market Segment by Drug
5.3.1 World Intravitreal Injectable Production by Drug (2019-2030)
5.3.2 World Intravitreal Injectable Production Value by Drug (2019-2030)
5.3.3 World Intravitreal Injectable Average Price by Drug (2019-2030)
6.1 World Intravitreal Injectable Market Size Overview by Disease: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Disease
6.2.1 Macular Degeneration
6.2.2 Macular Edema
6.2.3 Uveitis
6.2.4 Retinal Vein Occlusion
6.2.5 Others
6.3 Market Segment by Disease
6.3.1 World Intravitreal Injectable Production by Disease (2019-2030)
6.3.2 World Intravitreal Injectable Production Value by Disease (2019-2030)
6.3.3 World Intravitreal Injectable Average Price by Disease (2019-2030)
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Details
7.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
7.1.6 Regeneron Pharmaceuticals (Eylea) Competitive Strengths & Weaknesses
7.2 Allergan
7.2.1 Allergan Details
7.2.2 Allergan Major Business
7.2.3 Allergan Intravitreal Injectable Product and Services
7.2.4 Allergan Intravitreal Injectable Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Allergan Recent Developments/Updates
7.2.6 Allergan Competitive Strengths & Weaknesses
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Details
7.3.2 EyePoint Pharmaceuticals Major Business
7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
7.3.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Genentech
7.4.1 Genentech Details
7.4.2 Genentech Major Business
7.4.3 Genentech Intravitreal Injectable Product and Services
7.4.4 Genentech Intravitreal Injectable Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Genentech Recent Developments/Updates
7.4.6 Genentech Competitive Strengths & Weaknesses
7.5 Kanghong Pharmaceutical
7.5.1 Kanghong Pharmaceutical Details
7.5.2 Kanghong Pharmaceutical Major Business
7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Kanghong Pharmaceutical Recent Developments/Updates
7.5.6 Kanghong Pharmaceutical Competitive Strengths & Weaknesses
8.1 Intravitreal Injectable Industry Chain
8.2 Intravitreal Injectable Upstream Analysis
8.2.1 Intravitreal Injectable Core Raw Materials
8.2.2 Main Manufacturers of Intravitreal Injectable Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intravitreal Injectable Production Mode
8.6 Intravitreal Injectable Procurement Model
8.7 Intravitreal Injectable Industry Sales Model and Sales Channels
8.7.1 Intravitreal Injectable Sales Model
8.7.2 Intravitreal Injectable Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Intravitreal Injectable Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Intravitreal Injectable Production Value by Region (2019-2024) & (USD Million)
Table 3. World Intravitreal Injectable Production Value by Region (2025-2030) & (USD Million)
Table 4. World Intravitreal Injectable Production Value Market Share by Region (2019-2024)
Table 5. World Intravitreal Injectable Production Value Market Share by Region (2025-2030)
Table 6. World Intravitreal Injectable Production by Region (2019-2024) & (K Units)
Table 7. World Intravitreal Injectable Production by Region (2025-2030) & (K Units)
Table 8. World Intravitreal Injectable Production Market Share by Region (2019-2024)
Table 9. World Intravitreal Injectable Production Market Share by Region (2025-2030)
Table 10. World Intravitreal Injectable Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Intravitreal Injectable Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Intravitreal Injectable Major Market Trends
Table 13. World Intravitreal Injectable Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Intravitreal Injectable Consumption by Region (2019-2024) & (K Units)
Table 15. World Intravitreal Injectable Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Intravitreal Injectable Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Intravitreal Injectable Producers in 2023
Table 18. World Intravitreal Injectable Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Intravitreal Injectable Producers in 2023
Table 20. World Intravitreal Injectable Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Intravitreal Injectable Company Evaluation Quadrant
Table 22. World Intravitreal Injectable Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Intravitreal Injectable Production Site of Key Manufacturer
Table 24. Intravitreal Injectable Market: Company Product Type Footprint
Table 25. Intravitreal Injectable Market: Company Product Application Footprint
Table 26. Intravitreal Injectable Competitive Factors
Table 27. Intravitreal Injectable New Entrant and Capacity Expansion Plans
Table 28. Intravitreal Injectable Mergers & Acquisitions Activity
Table 29. United States VS China Intravitreal Injectable Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Intravitreal Injectable Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Intravitreal Injectable Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravitreal Injectable Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Intravitreal Injectable Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Intravitreal Injectable Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Intravitreal Injectable Production Market Share (2019-2024)
Table 37. China Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravitreal Injectable Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Intravitreal Injectable Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Intravitreal Injectable Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Intravitreal Injectable Production Market Share (2019-2024)
Table 42. Rest of World Based Intravitreal Injectable Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intravitreal Injectable Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravitreal Injectable Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Intravitreal Injectable Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Intravitreal Injectable Production Market Share (2019-2024)
Table 47. World Intravitreal Injectable Production Value by Drug, (USD Million), 2019 & 2023 & 2030
Table 48. World Intravitreal Injectable Production by Drug (2019-2024) & (K Units)
Table 49. World Intravitreal Injectable Production by Drug (2025-2030) & (K Units)
Table 50. World Intravitreal Injectable Production Value by Drug (2019-2024) & (USD Million)
Table 51. World Intravitreal Injectable Production Value by Drug (2025-2030) & (USD Million)
Table 52. World Intravitreal Injectable Average Price by Drug (2019-2024) & (US$/Unit)
Table 53. World Intravitreal Injectable Average Price by Drug (2025-2030) & (US$/Unit)
Table 54. World Intravitreal Injectable Production Value by Disease, (USD Million), 2019 & 2023 & 2030
Table 55. World Intravitreal Injectable Production by Disease (2019-2024) & (K Units)
Table 56. World Intravitreal Injectable Production by Disease (2025-2030) & (K Units)
Table 57. World Intravitreal Injectable Production Value by Disease (2019-2024) & (USD Million)
Table 58. World Intravitreal Injectable Production Value by Disease (2025-2030) & (USD Million)
Table 59. World Intravitreal Injectable Average Price by Disease (2019-2024) & (US$/Unit)
Table 60. World Intravitreal Injectable Average Price by Disease (2025-2030) & (US$/Unit)
Table 61. Regeneron Pharmaceuticals (Eylea) Basic Information, Manufacturing Base and Competitors
Table 62. Regeneron Pharmaceuticals (Eylea) Major Business
Table 63. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
Table 64. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
Table 66. Regeneron Pharmaceuticals (Eylea) Competitive Strengths & Weaknesses
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Intravitreal Injectable Product and Services
Table 70. Allergan Intravitreal Injectable Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Allergan Recent Developments/Updates
Table 72. Allergan Competitive Strengths & Weaknesses
Table 73. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. EyePoint Pharmaceuticals Major Business
Table 75. EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
Table 76. EyePoint Pharmaceuticals Intravitreal Injectable Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. EyePoint Pharmaceuticals Recent Developments/Updates
Table 78. EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Genentech Basic Information, Manufacturing Base and Competitors
Table 80. Genentech Major Business
Table 81. Genentech Intravitreal Injectable Product and Services
Table 82. Genentech Intravitreal Injectable Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Genentech Recent Developments/Updates
Table 84. Kanghong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 85. Kanghong Pharmaceutical Major Business
Table 86. Kanghong Pharmaceutical Intravitreal Injectable Product and Services
Table 87. Kanghong Pharmaceutical Intravitreal Injectable Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 88. Global Key Players of Intravitreal Injectable Upstream (Raw Materials)
Table 89. Intravitreal Injectable Typical Customers
Table 90. Intravitreal Injectable Typical Distributors
List of Figure
Figure 1. Intravitreal Injectable Picture
Figure 2. World Intravitreal Injectable Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Intravitreal Injectable Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Intravitreal Injectable Production (2019-2030) & (K Units)
Figure 5. World Intravitreal Injectable Average Price (2019-2030) & (US$/Unit)
Figure 6. World Intravitreal Injectable Production Value Market Share by Region (2019-2030)
Figure 7. World Intravitreal Injectable Production Market Share by Region (2019-2030)
Figure 8. North America Intravitreal Injectable Production (2019-2030) & (K Units)
Figure 9. Europe Intravitreal Injectable Production (2019-2030) & (K Units)
Figure 10. China Intravitreal Injectable Production (2019-2030) & (K Units)
Figure 11. Intravitreal Injectable Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 14. World Intravitreal Injectable Consumption Market Share by Region (2019-2030)
Figure 15. United States Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 16. China Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 17. Europe Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 18. Japan Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 19. South Korea Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 20. ASEAN Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 21. India Intravitreal Injectable Consumption (2019-2030) & (K Units)
Figure 22. Producer Shipments of Intravitreal Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 23. Global Four-firm Concentration Ratios (CR4) for Intravitreal Injectable Markets in 2023
Figure 24. Global Four-firm Concentration Ratios (CR8) for Intravitreal Injectable Markets in 2023
Figure 25. United States VS China: Intravitreal Injectable Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 26. United States VS China: Intravitreal Injectable Production Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Intravitreal Injectable Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States Based Manufacturers Intravitreal Injectable Production Market Share 2023
Figure 29. China Based Manufacturers Intravitreal Injectable Production Market Share 2023
Figure 30. Rest of World Based Manufacturers Intravitreal Injectable Production Market Share 2023
Figure 31. World Intravitreal Injectable Production Value by Drug, (USD Million), 2019 & 2023 & 2030
Figure 32. World Intravitreal Injectable Production Value Market Share by Drug in 2023
Figure 33. Anti-VEGF
Figure 34. Steroids
Figure 35. Others
Figure 36. World Intravitreal Injectable Production Market Share by Drug (2019-2030)
Figure 37. World Intravitreal Injectable Production Value Market Share by Drug (2019-2030)
Figure 38. World Intravitreal Injectable Average Price by Drug (2019-2030) & (US$/Unit)
Figure 39. World Intravitreal Injectable Production Value by Disease, (USD Million), 2019 & 2023 & 2030
Figure 40. World Intravitreal Injectable Production Value Market Share by Disease in 2023
Figure 41. Macular Degeneration
Figure 42. Macular Edema
Figure 43. Uveitis
Figure 44. Retinal Vein Occlusion
Figure 45. Others
Figure 46. World Intravitreal Injectable Production Market Share by Disease (2019-2030)
Figure 47. World Intravitreal Injectable Production Value Market Share by Disease (2019-2030)
Figure 48. World Intravitreal Injectable Average Price by Disease (2019-2030) & (US$/Unit)
Figure 49. Intravitreal Injectable Industry Chain
Figure 50. Intravitreal Injectable Procurement Model
Figure 51. Intravitreal Injectable Sales Model
Figure 52. Intravitreal Injectable Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Regeneron Pharmaceuticals (Eylea) Allergan EyePoint Pharmaceuticals Genentech Kanghong Pharmaceutical
Related Reports
06 Jun 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
